SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2594)11/2/1997 4:56:00 PM
From: BarryH   of 6136
 
I think both of you might be right..the long term valuation of AGPH could be $2.5MM,it's sales,earnings and pipeline should put in that league but nearterm things could be dicy.

This sector is subject to great swings because it is precieved as an unsafe haven. Just look at last April for proof of that. My own feeling is that there will be a flight for safety both within stocks and outside of them( to bonds). I'll continue to believe that as long as the yield curves and stock index move in the SAME direction as they did last week.

THe price of AGPH is a question of timing and how rational vs emotional the traders are...

Just my opinion..

BarryH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext